Shares of Chemed (CHE -7.9%) trade lower after a whistleblower accuses the firm of an extensive Medicare HMO scheme aimed at defrauding the government. The allegations were unveiled in a lawsuit filed in a federal case against the company.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs